Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GEn1E Lifesciences
GEn1E Lifesciences

GEn1E Lifesciences

Series B

AI-driven platform developing rapid, novel therapies for rare and inflammatory diseases.

HQ
Palo Alto, CA, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorS19
Overview
Compare
Fundraising
Employees

GEn1E Lifesciences, founded with the mission to accelerate the development of therapies for rare and inflammatory diseases, leverages an advanced AI platform to create novel immunomodulatory treatments. The company focuses on addressing diseases with no effective treatments by applying AI to multiple-mechanism-of-action protein targets. Their core product offerings include precision therapies developed at an unprecedented pace, with a notable focus on conditions such as Acute Respiratory Distress Syndrome (ARDS).

Key figures affiliated with GEn1E Lifesciences include experts in AI and drug development, though specific names are not provided. The company's AI platform, GRID™, has been instrumental in discovering new binding pockets and validating unique mechanisms of action, contributing to significant advancements in the field. GEn1E's impact is marked by its potential to unlock billion-dollar opportunities in the pharmaceutical industry, positioning it as a transformative player in the development of first-in-class therapies for complex diseases.

GEn1E Lifesciences - Similar Companies

1910 Genetics logo

1910 Genetics

1910genetics.com

Genesis Therapeutics logo

Genesis Therapeutics

Generate Biomedicines logo

Generate Biomedicines

Synkrino Biotherapeutics logo

Synkrino Biotherapeutics

Ordaos logo

Ordaos

ordaos.bio

Arpeggio Bio logo

Arpeggio Bio

arpeggiobio.com

Output Biosciences logo

Output Biosciences

outputbio.com

Probably Genetic logo

Probably Genetic

WhiteLab Genomics logo

WhiteLab Genomics

whitelabgx.com

Diffuse Bio logo

Diffuse Bio

diffuse.bio

Emedgene logo

Emedgene

emedgene.com

Endpoint Health logo

Endpoint Health

endpointhealth.com

OneThree Biotech logo

OneThree Biotech

onethree.bio

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Genemod logo

Genemod

genemod.net

GEn1E Lifesciences - Quick Facts

Who are GEn1E Lifesciences' competitors?

Companies similar to GEn1E Lifesciences include 1910 Genetics, Genesis Therapeutics, Generate Biomedicines and Synkrino Biotherapeutics.

When was GEn1E Lifesciences founded?

GEn1E Lifesciences was founded in 2018.

Where is GEn1E Lifesciences' headquarters located?

GEn1E Lifesciences' headquarters is located in Palo Alto, CA, US.

When was GEn1E Lifesciences' last funding round?

GEn1E Lifesciences' most recent funding round was for $17M (USD) in December 2022.

How much has GEn1E Lifesciences raised to-date?

As of Dec 21, 2022, GEn1E Lifesciences has raised a total of $17M (USD).

How many employees does GEn1E Lifesciences have?

GEn1E Lifesciences has 16 employees as of Feb 5, 2024.

GEn1E Lifesciences - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified